Doping Directory by RaceVuelta a Guatemala |
|
Last update -
cyclisme-dopage.com
| Rider | Product | Year | Sanction | Control |
| Paredes Nicolás | Stanozolol | 2025 | Yes | Positive control |
| Rosero Nixon | Clostebol | 2023 | Yes | Positive control |
| 4037 | 2022 | Yes | Positive control | |
| 3634 | 2018 | Yes | Positive control | |
| 3353 | Blood transfusion | 2018 | Yes | Positive control |
| 2735 | Hydrochlorothiazide | 2013 | Yes | Positive control |
| 2748 | GW501516 | 2012 | Yes | Positive control |
| 2249 | Boldénone | 2009 | Yes | Positive control |
| 1235 | Boldénone | 2009 | Yes | Positive control |
| 14 | EPO | 2004 | Yes | Positive control |
| Bony Pérez Augusto | 2004 | Yes | Disciplinary investigation | |
| 172 | Acétonide de triamcinolone | 2004 | Yes | Positive control |
| 311 | EPO | 2004 | Yes | Contrôle positif et aveux en 2005 |
| Diaz Daniel Ricardo | 2004 | Yes | Positive control | |
| 581 | Testosterone | 2004 | Yes | Positive control |
| Lopez Gonzales Carlos | EPO, testostérone | 2004 | Yes | Positive control |
| Lopez Majia Jose-Enrique | 2004 | Yes | Enquête UCI | |
| Munoz Fernandez Federico | EPO | 2004 | Yes | Positive control |
| 842 | EPO | 2004 | Yes | Positive control |
| 917 | 2004 | Yes | Positive control | |
| Pineda Fernando | 2004 | Yes | Disciplinary investigation | |
| 977 | 2004 | Yes | Positive control | |
| 978 | 2004 | Yes | Positive control | |
| 1048 | 2004 | Yes | Positive control | |
| 1232 | EPO | 2004 | Yes | Positive control |
| 1235 | EPO | 2004 | Yes | Positive control |
| Dickey Duane | Phentermine, Boldénone, nandrolone | 2001 | Yes | Positive control |
| Gonzalez Victor Hugo | Lidocaïne | 2001 | Unknown | Positive control |
| 774 | Testosterone | 2001 | Unknown | Positive control |
| Sarmiento Ismaël | Testosterone | 2001 | Unknown | Positive control |
| 1104 | Ephedrine | 2001 | Unknown | Positive control |
For a good understanding, the following should be kept in mind:
If you notice any errors or omissions, please let us know by sending a message here .